Polymyalgia rheumatica in a melanoma patient due to nivolumab treatment

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38(5):434–439

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. Dasgupta B, Cimmino MA, Maradit-Kremers H et al (2012) provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71(4):484–492

    Article  PubMed  PubMed Central  Google Scholar 

  3. Jacob A, Unnikrishnan DC, Mathew A, Thyagarajan B, Patel S (2016) A case of fatal Guillain–Barre syndrome from anti-PD1 monoclonal antibody use. J Cancer Res Clin Oncol 142(8):1869–1870

    Article  PubMed  Google Scholar 

  4. Kimura T, Fukushima S, Miyashita A et al (2016) Myasthenic crisis and polymyositis induced by one dose of nivolumab. Cancer Sci 107(7):1055–1058

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. Larkin J, Hodi FS, Wolchok JD (2015) Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 373(13):1270–1271

    Article  PubMed  Google Scholar 

  6. Wang C, Thudium KB, Han M et al (2014) In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res 2(9):846–856

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by JSPS KAKENHI Grant number JP 26460901.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Kiyotaka Nakamagoe.

Ethics declarations

Conflict of interest

All authors declare no conflicts of interests.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from an individual participant included in the case.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nakamagoe, K., Moriyama, T., Maruyama, H. et al. Polymyalgia rheumatica in a melanoma patient due to nivolumab treatment. J Cancer Res Clin Oncol 143, 1357–1358 (2017). https://doi.org/10.1007/s00432-017-2410-x

Download citation

Keywords

  • Bursitis
  • Biceps Brachii
  • Morning Stiffness
  • Tenosynovitis
  • Polymyalgia Rheumatica